Raymond James Financial Services Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $482K | Buy |
|
|||||
|
2024
Q2 | $537K | Sell |
|
|||||
|
2024
Q1 | $647K | Buy |
|
|||||
|
2023
Q4 | $708K | Sell |
|
|||||
|
2023
Q3 | $1.93M | Buy |
|
|||||
|
2023
Q2 | $1.7M | Sell |
|
|||||
|
2023
Q1 | $2.23M | Buy |
|
|||||
|
2022
Q4 | $1.48M | Sell |
|
|||||
|
2022
Q3 | $1.29M | Buy |
|
|||||
|
2022
Q2 | $1.19M | Sell |
|
|||||
|
2022
Q1 | $1.3M | Buy |
|
|||||
|
2021
Q4 | $456K | Sell |
|
|||||
|
2021
Q3 | $791K | Sell |
|
|||||
|
2021
Q2 | $1.05M | Buy |
|
|||||
|
2021
Q1 | $588K | Buy |
|
|||||
|
2020
Q4 | $471K | Buy |
|
|||||
|
2020
Q3 | $323K | Sell |
|
|||||
|
2020
Q2 | $528K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $403K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $206K | Sell |
|
|||||
|
2019
Q1 | $295K | Buy |
|
|||||
|
2018
Q4 | $234K | Sell |
|
|||||
|
2018
Q3 | $336K | Buy |
|
|||||
|
2018
Q2 | $247K | Sell |
|
|||||
|
2018
Q1 | $253K | Buy |
|
|||||
|
2017
Q4 | $224K | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $991K | Buy |
|
|||||
|
2016
Q4 | $317K | Sell |
|
|||||
|
2016
Q3 | $720K | Sell |
|
|||||
|
2016
Q2 | $934K | Buy |
|
|||||
|
2016
Q1 | $405K | Buy |
|